Healthcare generally is a priority enforcement sector for competition watchdogs across the world, including the UK’s Competition and...

University spin-out companies offer a means of commercialising valuable intellectual property (IP) and technology generated through...

On 22 July 2025, the UK Government signalled that it is likely to pivot back to indefinite recognition of CE Marking of devices. In a...

AI presents many opportunities in the women’s health space, but it can also pose considerable risks. Anyone seeking to commercialise...

Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...

Earlier this month, Ellen Lambrix and Luca Cericola from Bristows’ Commercial & IP Transactions team attended the Licensing Executives...

The FemTech sector — technology focused on women’s health and wellness — is experiencing rapid growth in the UK. Out of the 540 active...

We explore the complexities of navigating share option plans on both sides of the Atlantic. For companies looking to reward employees...

One of the key challenges with closing the women’s health gap and expanding the number of offerings available to women (in an industry...

Femtech, short for female technology, is an important and fast growing sector. The UK is a key market for femtech as it is ranked second...

While women’s health research has been historically overlooked and underfunded, in recent years there has been a surge of activity...

In this final episode of our three-part mini series on the EU AI Act and its implications for manufacturers of medical devices, Marc...